Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics

2023/11/04 by Yi-Hsuan Chiang, Yi‐Hsuan Chiang, Chih‐Ning Cheng +12 · 3 citations
Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics · Medicine · #Metabolomics and Mass Spectrometry Studies #Drug-Induced Hepatotoxicity and Protection #Antifungal resistance and susceptibility

paper · doi:10.1016/j.ijantimicag.2023.107028

Citations

• ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

Cited by

• Changes in the blood cyclosporine level after switching from voriconazole to isavuconazole in a patient with aplastic anemia: insights from physiologically based pharmacokinetic model simulation and the Adverse Event Reporting System database study. [europepmc]
• Voriconazole-induced liver injury: incidence patterns and risk factors in a retrospective cohort. [europepmc]
• Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants. [europepmc]